## **Core Concept**
Beta-glucosidase is an enzyme that breaks down certain lipids, particularly **glucocerebroside**, into glucose and ceramide. A deficiency in this enzyme leads to the accumulation of glucocerebroside within cells, primarily affecting the **lysosomes** of macrophages.

## **Why the Correct Answer is Right**
The correct answer, **Gaucher's disease**, is caused by a deficiency of the enzyme **beta-glucosidase** (also known as **glucocerebrosidase**). This deficiency results in the accumulation of **glucocerebroside** within the lysosomes of macrophages, which then become **Gaucher cells**. These cells accumulate in various organs, including the liver, spleen, and bone marrow, leading to the clinical manifestations of Gaucher's disease.

## **Why Each Wrong Option is Incorrect**
- **Option A: Metachromatic Leukodystrophy** - This condition is caused by a deficiency of the enzyme **arylsulfatase A**, leading to the accumulation of **sulfatides** in the nervous system and other tissues. It is not related to beta-glucosidase deficiency.
- **Option B: Tay-Sachs disease** - This is caused by a deficiency of the enzyme **hexosaminidase A**, leading to the accumulation of **GM2 ganglioside** within neurons. It is not related to beta-glucosidase deficiency.
- **Option C: Niemann-Pick disease** - This group of diseases is caused by deficiencies in **sphingomyelinase** or other genes involved in lipid metabolism, leading to the accumulation of **sphingomyelin**. It is not caused by beta-glucosidase deficiency.

## **Clinical Pearl / High-Yield Fact**
A key clinical pearl is that Gaucher's disease is one of the **lysosomal storage diseases** and can present with **hepatosplenomegaly**, **bone pain**, and **fatigue**. It is particularly prevalent in individuals of **Ashkenazi Jewish descent**.

## **Correct Answer:** D. Gaucher's disease